ClinConnect ClinConnect Logo
Search / Trial NCT05908123

Exploring the Nature, Assessment and Treatment of Stuttering

Launched by UNIVERSITY OF TEXAS AT AUSTIN · Jun 8, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Stuttering, Communication Competence, Adult, Treatment

ClinConnect Summary

This clinical trial is studying stuttering, which affects both children and adults. The researchers want to understand what causes stuttering and how it affects people’s speech, language, and emotional well-being. They also aim to explore different treatment methods, including online therapy and training for speech therapists, to help those who stutter improve their fluency.

If you or your child stutters, you may be eligible to participate in this study. Children between the ages of 2 and 17 can join if their parent or caregiver has concerns about their speech, or if they show specific signs of stuttering. Adults aged 18 and older can participate if they have been diagnosed with stuttering by a certified speech-language pathologist. There are no exclusion criteria, meaning anyone who stutters can potentially be involved. Participants will have the opportunity to contribute to important research while also exploring various treatment options that could help them manage their stuttering better.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • A participant will be considered a child who stutters (ages 2-17 years) if
  • their parent/caregiver reports concern that their child is a person who stutters,
  • they exhibit three of more stuttering-like disfluencies (e.g., sound/syllable repetitions, (in)audible sound prolongations, whole-word repetitions) per 300-word speech sample, or
  • they present with an overall score of 11 or higher on the Stuttering Severity Instrument - 4th Edition (SSI-4).
  • A participant will be considered an adult who stutters (18+ years) if
  • they report they are a person who stutters,
  • they have received a formal diagnosis of stuttering from a certified speech-language pathologist,
  • they exhibit three of more stuttering-like disfluencies (e.g., sound/syllable repetitions, (in)audible sound prolongations, whole-word repetitions) per 300-word speech sample, or
  • they present with an overall score of 11 or higher on the Stuttering Severity Instrument - 4th Edition (SSI-4).
  • Exclusion Criteria:
  • • There are no exclusion criteria for persons who stutter.

About University Of Texas At Austin

The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.

Locations

Austin, Texas, United States

Patients applied

0 patients applied

Trial Officials

Courtney T Byrd, PhD

Principal Investigator

The University of Texas at Austin

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported